Cannabis Industry Growth Projections: Is the Market Really Heading to $100 Billion by 2030?

The Growth Story: Where the Numbers Stand

The global legal cannabis market is widely projected to reach values ranging from $57 billion to over $110 billion by 2030, depending on the source and methodology used. The U.S. alone is expected to contribute between $43 billion and $76 billion of that total.

These projections reflect optimism about continued state-level legalization, rising medical applications, and greater consumer acceptance. But the path forward is far from linear.

What's Driving Growth

• Legalization momentum: More countries and U.S. states are legalizing medical and recreational cannabis, expanding the addressable market.
• Medical applications: Growing research into therapeutic uses of cannabinoids is opening pharmaceutical channels.
• Consumer normalization: Cannabis is increasingly viewed as a mainstream wellness product, not a fringe substance.
• Product diversification: Categories like beverages, topicals, and precision edibles are attracting new consumer demographics.

The Headwinds

Not all signals are bullish. The market experienced a rare year-over-year revenue decline in 2025 due to supply saturation and pricing pressure. Key challenges include:

• Price compression: Increased supply is driving wholesale prices down, squeezing margins for cultivators and processors.
• Regulatory fragmentation: Without federal legalization, the U.S. market remains a patchwork of 50 different regulatory environments.
• Illicit market competition: In many states, the unlicensed market continues to undercut legal operators on price.

Regional Outlook

North America remains the dominant market, but other regions are emerging:

• Europe: Germany leads the continent's medical market, with the Czech Republic joining the legalization wave in 2026.
• Latin America: Brazil has surpassed 873,000 registered medical cannabis patients, and Colombia is positioning itself as an export hub.
• Asia-Pacific: Thailand's evolving framework and Australia's medical program represent nascent but growing opportunities.

What Investors Should Watch

The divergence between projections reflects different assumptions about federal reform, interstate commerce, and the pace of illicit-to-legal market conversion. Savvy investors should focus on operators with strong unit economics, diversified revenue streams, and exposure to high-barrier-to-entry markets.